Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Thyroid Cancer Detection
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Overview
Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?